{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T16:18:58Z","timestamp":1781885938704,"version":"3.54.5"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T00:00:00Z","timestamp":1667952000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T00:00:00Z","timestamp":1667952000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Neurovirol."],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1007\/s13365-022-01105-z","type":"journal-article","created":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T19:03:47Z","timestamp":1668020627000},"page":"100-105","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Seropositivity and reactivations of HSV-1, but not of HSV-2 nor VZV, associate with altered blood\u2013brain barrier, beta amyloid, and tau proteins in people living with HIV"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8663-719X","authenticated-orcid":false,"given":"Mattia","family":"Trunfio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Di Girolamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Ponzetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Burdino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Imperiale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiana","family":"Atzori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Di Perri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Calcagno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,9]]},"reference":[{"key":"1105_CR1","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1111\/j.1532-5415.2006.00796.x","volume":"54","author":"AE Aiello","year":"2006","unstructured":"Aiello AE, Haan M, Blythe L et al (2006) The influence of latent viral infection on rate of cognitive decline over 4 years. J Am Geriatr Soc 54:1046\u20131054. https:\/\/doi.org\/10.1111\/j.1532-5415.2006.00796.x","journal-title":"J Am Geriatr Soc"},{"key":"1105_CR2","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1002\/jnr.23003","volume":"90","author":"G Alvarez","year":"2012","unstructured":"Alvarez G, Aldudo J, Alonso M et al (2012) Herpes simplex virus type 1 induces nuclear accumulation of hyperphosphorylated tau in neuronal cells. J Neurosci Res 90:1020\u20131029. https:\/\/doi.org\/10.1002\/jnr.23003","journal-title":"J Neurosci Res"},{"key":"1105_CR3","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.3233\/JAD-150652","volume":"50","author":"K Bourgade","year":"2016","unstructured":"Bourgade K, Le Page A, Bocti C et al (2016) Protective effect of amyloid-\u03b2 peptides against herpes simplex virus-1 infection in a neuronal cell culture model. J Alzheimers Dis 50:1227\u20131241. https:\/\/doi.org\/10.3233\/JAD-150652","journal-title":"J Alzheimers Dis"},{"key":"1105_CR4","doi-asserted-by":"publisher","first-page":"e627","DOI":"10.1212\/CPJ.0000000000001060","volume":"11","author":"A Calcagno","year":"2021","unstructured":"Calcagno A, Celani L, Trunfio M et al (2021) Alzheimer dementia in people living with HIV. Neurol Clin Pract 11:e627\u2013e633. https:\/\/doi.org\/10.1212\/CPJ.0000000000001060","journal-title":"Neurol Clin Pract"},{"key":"1105_CR5","doi-asserted-by":"publisher","first-page":"867","DOI":"10.3390\/diagnostics11050867","volume":"11","author":"G Caligaris","year":"2021","unstructured":"Caligaris G, Trunfio M, Ghisetti V et al (2021) Blood-brain barrier impairment in patients living with HIV: predictors and associated biomarkers. Diagnostics (basel) 11:867. https:\/\/doi.org\/10.3390\/diagnostics11050867","journal-title":"Diagnostics (basel)"},{"key":"1105_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007617","volume":"15","author":"G De Chiara","year":"2019","unstructured":"De Chiara G, Piacentini R, Fabiani M et al (2019) Recurrent herpes simplex virus-1 infection induces hallmarks of neurodegeneration and cognitive deficits in mice. PLoS Pathog 15:e1007617. https:\/\/doi.org\/10.1371\/journal.ppat.1007617","journal-title":"PLoS Pathog"},{"key":"1105_CR7","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-032112","volume":"10","author":"DP Devanand","year":"2020","unstructured":"Devanand DP, Andrews H, Kreisl WC et al (2020) Antiviral therapy: valacyclovir treatment of Alzheimer\u2019s disease (VALAD) trial: protocol for a randomised, double-blind, placebo-controlled, treatment trial. BMJ Open 10:e032112. https:\/\/doi.org\/10.1136\/bmjopen-2019-032112","journal-title":"BMJ Open"},{"key":"1105_CR8","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1097\/QAD.0000000000002506","volume":"34","author":"JA Fields","year":"2020","unstructured":"Fields JA, Swinton MK, Soontornniyomkij B et al (2020) Beta amyloid levels in cerebrospinal fluid of HIV-infected people vary by exposure to antiretroviral therapy. AIDS 34:1001\u20131007. https:\/\/doi.org\/10.1097\/QAD.0000000000002506","journal-title":"AIDS"},{"key":"1105_CR9","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3389\/fnagi.2018.00048","volume":"10","author":"SA Harris","year":"2018","unstructured":"Harris SA, Harris EA (2018) Molecular mechanisms for herpes simplex virus type 1 pathogenesis in Alzheimer\u2019s disease. Front Aging Neurosci 10:48. https:\/\/doi.org\/10.3389\/fnagi.2018.00048","journal-title":"Front Aging Neurosci"},{"key":"1105_CR10","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1007\/s13365-019-00736-z","volume":"25","author":"A Hategan","year":"2019","unstructured":"Hategan A, Masliah E, Nath A (2019) HIV and Alzheimer\u2019s disease: complex interactions of HIV-Tat with amyloid \u03b2 peptide and Tau protein. J Neurovirol 25:648\u2013660. https:\/\/doi.org\/10.1007\/s13365-019-00736-z","journal-title":"J Neurovirol"},{"key":"1105_CR11","doi-asserted-by":"publisher","first-page":"679","DOI":"10.3390\/vaccines9060679","volume":"9","author":"RF Itzhaki","year":"2021","unstructured":"Itzhaki RF (2021) Overwhelming evidence for a major role for herpes simplex virus type 1 (HSV1) in Alzheimer\u2019s disease (AD); underwhelming evidence against. Vaccines (basel) 9:679. https:\/\/doi.org\/10.3390\/vaccines9060679","journal-title":"Vaccines (basel)"},{"key":"1105_CR12","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.bbrc.2012.12.054","volume":"430","author":"N Kobayashi","year":"2013","unstructured":"Kobayashi N, Nagata T, Shinagawa S et al (2013) Increase in the IgG avidity index due to herpes simplex virus type 1 reactivation and its relationship with cognitive function in amnestic mild cognitive impairment and Alzheimer\u2019s disease. Biochem Biophys Res Commun 430:907\u2013911. https:\/\/doi.org\/10.1016\/j.bbrc.2012.12.054","journal-title":"Biochem Biophys Res Commun"},{"key":"1105_CR13","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1093\/cid\/ciy170","volume":"67","author":"S Letendre","year":"2018","unstructured":"Letendre S, Bharti A, Perez-Valero I et al (2018) Higher anti-cytomegalovirus immunoglobulin G concentrations are associated with worse neurocognitive performance during suppressive antiretroviral therapy. Clin Infect Dis 67:770\u2013777. https:\/\/doi.org\/10.1093\/cid\/ciy170","journal-title":"Clin Infect Dis"},{"key":"1105_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/trc2.12119","volume":"7","author":"K Lopatko Lindman","year":"2021","unstructured":"Lopatko Lindman K, Hemmingsson E-S, Weidung B et al (2021) Herpesvirus infections, antiviral treatment, and the risk of dementia-a registry-based cohort study in Sweden. Alzheimers Dement (n y) 7:e12119. https:\/\/doi.org\/10.1002\/trc2.12119","journal-title":"Alzheimers Dement (n y)"},{"key":"1105_CR15","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.jalz.2014.04.522","volume":"11","author":"H L\u00f6vheim","year":"2015","unstructured":"L\u00f6vheim H, Gilthorpe J, Adolfsson R et al (2015) Reactivated herpes simplex infection increases the risk of Alzheimer\u2019s disease. Alzheimers Dement 11:593\u2013599. https:\/\/doi.org\/10.1016\/j.jalz.2014.04.522","journal-title":"Alzheimers Dement"},{"key":"1105_CR16","first-page":"E27","volume":"58","author":"S Marchi","year":"2017","unstructured":"Marchi S, Trombetta CM, Gasparini R et al (2017) Epidemiology of herpes simplex virus type 1 and 2 in Italy: a seroprevalence study from 2000 to 2014. J Prev Med Hyg 58:E27\u2013E33","journal-title":"J Prev Med Hyg"},{"key":"1105_CR17","doi-asserted-by":"publisher","first-page":"e01874","DOI":"10.1128\/JVI.01874-19","volume":"94","author":"RD Powell-Doherty","year":"2020","unstructured":"Powell-Doherty RD, Abbott ARN, Nelson LA, Bertke AS (2020) Amyloid-\u03b2 and p-tau anti-threat response to herpes simplex virus 1 infection in primary adult murine hippocampal neurons. J Virol 94:e01874-e1919. https:\/\/doi.org\/10.1128\/JVI.01874-19","journal-title":"J Virol"},{"key":"1105_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2022.102200","volume":"63","author":"V Protto","year":"2022","unstructured":"Protto V, Marcocci ME, Miteva MT et al (2022) Role of HSV-1 in Alzheimer\u2019s disease pathogenesis: a challenge for novel preventive\/therapeutic strategies. Curr Opin Pharmacol 63:102200. https:\/\/doi.org\/10.1016\/j.coph.2022.102200","journal-title":"Curr Opin Pharmacol"},{"key":"1105_CR19","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1097\/QAD.0000000000001927","volume":"32","author":"V Soontornniyomkij","year":"2018","unstructured":"Soontornniyomkij V, Umlauf A, Soontornniyomkij B et al (2018) Association of antiretroviral therapy with brain aging changes among HIV-infected adults. AIDS 32:2005\u20132015. https:\/\/doi.org\/10.1097\/QAD.0000000000001927","journal-title":"AIDS"},{"key":"1105_CR20","doi-asserted-by":"publisher","first-page":"753","DOI":"10.3390\/v14040753","volume":"14","author":"M Trunfio","year":"2022","unstructured":"Trunfio M, Atzori C, Pasquero M et al (2022) Patterns of cerebrospinal fluid Alzheimer\u2019s dementia biomarkers in people living with HIV: cross-sectional study on associated factors according to viral control, neurological confounders and neurocognition. Viruses 14:753. https:\/\/doi.org\/10.3390\/v14040753","journal-title":"Viruses"},{"key":"1105_CR21","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s13311-018-0611-x","volume":"15","author":"N-S Tzeng","year":"2018","unstructured":"Tzeng N-S, Chung C-H, Lin F-H et al (2018) Anti-herpetic medications and reduced risk of dementia in patients with herpes simplex virus infections\u2014a nationwide, population-based cohort study in Taiwan. Neurotherapeutics 15:417\u2013429. https:\/\/doi.org\/10.1007\/s13311-018-0611-x","journal-title":"Neurotherapeutics"},{"key":"1105_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/trc2.12264","volume":"8","author":"B Weidung","year":"2022","unstructured":"Weidung B, Hemmingsson E-S, Olsson J et al (2022) VALZ-Pilot: high-dose valacyclovir treatment in patients with early-stage Alzheimer\u2019s disease. Alzheimers Dement (n y) 8:e12264. https:\/\/doi.org\/10.1002\/trc2.12264","journal-title":"Alzheimers Dement (n y)"},{"key":"1105_CR23","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1086\/340041","volume":"185","author":"F Xu","year":"2002","unstructured":"Xu F, Schillinger JA, Sternberg MR et al (2002) Seroprevalence and coinfection with herpes simplex virus type 1 and type 2 in the United States, 1988\u20131994. J Infect Dis 185:1019\u20131024. https:\/\/doi.org\/10.1086\/340041","journal-title":"J Infect Dis"},{"key":"1105_CR24","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2020-002388","volume":"5","author":"W Yousuf","year":"2020","unstructured":"Yousuf W, Ibrahim H, Harfouche M et al (2020) Herpes simplex virus type 1 in Europe: systematic review, meta-analyses and meta-regressions. BMJ Glob Health 5:e002388. https:\/\/doi.org\/10.1136\/bmjgh-2020-002388","journal-title":"BMJ Glob Health"},{"key":"1105_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.816098","volume":"8","author":"N Zhang","year":"2021","unstructured":"Zhang N, Zuo Y, Jiang L et al (2021) Epstein-Barr virus and neurological diseases. Front Mol Biosci 8:816098. https:\/\/doi.org\/10.3389\/fmolb.2021.816098","journal-title":"Front Mol Biosci"}],"container-title":["Journal of NeuroVirology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13365-022-01105-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13365-022-01105-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13365-022-01105-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T14:56:01Z","timestamp":1681224961000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13365-022-01105-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,9]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["1105"],"URL":"https:\/\/doi.org\/10.1007\/s13365-022-01105-z","relation":{},"ISSN":["1355-0284","1538-2443"],"issn-type":[{"value":"1355-0284","type":"print"},{"value":"1538-2443","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,9]]},"assertion":[{"value":"31 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}